On Friday, June 13, a federal judge officially sided with the FDA and Novo Nordisk in the lawsuit brought by the Outsourcing Facilities Association over compounded semaglutide.
We don’t use compound because of shortage (primarily). We use it because WE cannot AFFORD BRAND NAME! Recognizing and treating obesity is simply not accepted by far too many!
We all know this is “hogwash,” as my grandad used to say. Same with the Tirzepitide lawsuit. More people endangered because they’re now forced to the “gray” market.
We don’t use compound because of shortage (primarily). We use it because WE cannot AFFORD BRAND NAME! Recognizing and treating obesity is simply not accepted by far too many!
Let’s get the prices down!
We all know this is “hogwash,” as my grandad used to say. Same with the Tirzepitide lawsuit. More people endangered because they’re now forced to the “gray” market.
It is obesity hate and prejudice. Insurance companies pay for sleep apnea on the spot for GLP1 but not for chronic disease obesity
I wonder how large the bribe to the judge was. I don’t say that lightly.